CFRXQ — CONTRAFECT Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$5.41m
Annual balance sheet for CONTRAFECT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 30.5 | 24.2 | 42.5 | 54.3 | 13.7 |
Net Total Receivables | — | — | — | 4.1 | 2.6 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 31.4 | 30.8 | 46.7 | 62.9 | 17.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.08 | 4.14 | 3.72 | 3.29 | 2.87 |
Other Long Term Assets | |||||
Total Assets | 32.9 | 35 | 51.1 | 66.8 | 20.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 5.8 | 10.1 | 6.06 | 12.2 | 20.8 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 27.3 | 19.5 | 38.5 | 17.4 | 32.5 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.54 | 15.5 | 12.6 | 49.4 | -11.9 |
Total Liabilities & Shareholders' Equity | 32.9 | 35 | 51.1 | 66.8 | 20.7 |
Total Common Shares Outstanding |